Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Biological Psychiatry
|
November 18, 2017
Maternal Immune Activation Delays Excitatory-to-Inhibitory Gamma-Aminobutyric Acid Switch in Offspring
Irene Corradini, Elisa Focchi, Marco Rasile, et al.
Journal of Medicinal Chemistry
|
February 25, 2017
Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers
Romain Siegrist, Davide Pozzi, Gaël Jacob, et al.
Iscience
|
March 12, 2024
<i>Mecp2</i> knock-out astrocytes affect synaptogenesis by interleukin 6 dependent mechanisms
Elena Albizzati, Martina Breccia, Elena Florio, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers
Romain Siegrist, Davide Pozzi, Gaël Jacob, et al.
The EMBO Journal
|
May 15, 2023
Maternal immune activation leads to defective brain blood vessels and intracerebral hemorrhages in male offspring
Marco Rasile, Eliana Lauranzano, Elisa Faggiani, et al.
EMBO Molecular Medicine
|
March 5, 2021
The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes
Linda Scaramuzza, Giuseppina De Rocco, Genni Desiato, et al.
The EMBO Journal
|
October 31, 2022
Maternal immune activation leads to defective brain-blood vessels and intracerebral hemorrhages in male offspring
Marco Rasile, Eliana Lauranzano, Elisa Faggiani, et al.
Brain, Behavior, and Immunity
|
October 26, 2017
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis
Fabrizia C Guarnieri, Serena Bellani, Latefa Yekhlef, et al.
Chemmedchem
|
April 7, 2025
Discovery of ACT-1002-4271 as a Dual Prostaglandin E2 Receptor 2/Prostaglandin E2 Receptor 4 Antagonist with In Vivo Anti-Tumor Efficacy
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Chemmedchem
|
April 7, 2025
Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Biological Psychiatry
|
November 18, 2017
Maternal Immune Activation Delays Excitatory-to-Inhibitory Gamma-Aminobutyric Acid Switch in Offspring
Irene Corradini, Elisa Focchi, Marco Rasile, et al.
Journal of Medicinal Chemistry
|
February 25, 2017
Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers
Romain Siegrist, Davide Pozzi, Gaël Jacob, et al.
Iscience
|
March 12, 2024
<i>Mecp2</i> knock-out astrocytes affect synaptogenesis by interleukin 6 dependent mechanisms
Elena Albizzati, Martina Breccia, Elena Florio, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers
Romain Siegrist, Davide Pozzi, Gaël Jacob, et al.
The EMBO Journal
|
May 15, 2023
Maternal immune activation leads to defective brain blood vessels and intracerebral hemorrhages in male offspring
Marco Rasile, Eliana Lauranzano, Elisa Faggiani, et al.
EMBO Molecular Medicine
|
March 5, 2021
The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes
Linda Scaramuzza, Giuseppina De Rocco, Genni Desiato, et al.
The EMBO Journal
|
October 31, 2022
Maternal immune activation leads to defective brain-blood vessels and intracerebral hemorrhages in male offspring
Marco Rasile, Eliana Lauranzano, Elisa Faggiani, et al.
Brain, Behavior, and Immunity
|
October 26, 2017
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis
Fabrizia C Guarnieri, Serena Bellani, Latefa Yekhlef, et al.
Chemmedchem
|
April 7, 2025
Discovery of ACT-1002-4271 as a Dual Prostaglandin E2 Receptor 2/Prostaglandin E2 Receptor 4 Antagonist with In Vivo Anti-Tumor Efficacy
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Chemmedchem
|
April 7, 2025
Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
Isabelle Lyothier, Stefan Diethelm, Julien Pothier, et al.
Page
of 6